Searched for
GLAND PHARMA BLOCK DEAL
Societe General, Prudential, others buy 3 per cent stake in Anthem Biosciences for Rs 1,275 crGlobal investors including Societe Generale and Prudential Hong Kong, alongside Indian mutual funds and insurance companies, have bought a ...- Aurobindo Pharma clears key US hurdle in Lannett acquisition, closing expected soonIndian drug giant Aurobindo Pharma is set for a major US expansion. The company has received crucial antitrust clearance from the US Federa...
- HC questions Telegram ban ahead of NEET retestDelhi High Court questioned the government's ban on Telegram for 150 million users ahead of the NEET re-examination. The court asked if res...
- HC questions Telegram ban ahead of NEET re-testThe Delhi High Court questioned the government's decision to temporarily ban Telegram for millions of users. This ban was imposed before th...
- US FTC imposes divestment condition on Aurobindo Pharma's $250 mn Lannett acquisitionThe U.S. Federal Trade Commission (FTC) has mandated that Aurobindo Pharma must sell off four specific drug products. This action is a cond...
- Trump Iran deal full text, key highlights, clauses: What is in it?Trump Iran deal includes key issues such as the reopening of Strat of Hormuz and nuclear weapons sanctions.
- HDFC MF, ADIA among buyers as Sepia Investments offloads Rs 749 crore in Corona Remedies via block dealSepia Investments and Anchor Partners sold shares worth about Rs 777 crore in Corona Remedies through block deals. HDFC Mutual Fund emerged...
- US-Iran deal allows Tehran to immediately sell oil: ReportAmerica will permit Iran to start selling oil and fuel immediately. This follows a memorandum of understanding to end a war. Sanctions on I...
- Barack Obama says Trump Iran deal will not improve on his pactFormer US President Barack Obama stated that any new deal with Iran is unlikely to be a major improvement over his 2015 nuclear agreement. ...
- US Justice Department clears Paramount's acquisition of Warner BrosThe U.S. Justice Department has approved Paramount Skydance Corp's massive $110 billion acquisition of Warner Bros. Discovery. This regulat...
- Lenskart block deal; Meesho's kirana pushLenskart has drawn fresh interest from major institutional investors. This and more in today's ETtech Top 5.
- Quant Small Cap Fund raises stake in Adani Enterprises and 8 others, trims in Aurobindo Pharma and 4 moreQuant Small Cap Fund increased exposure to Adani Enterprises and eight other stocks in May while reducing holdings in Aurobindo Pharma and ...
- Block deal: Goldman Sachs picks stake in this smallcap stock that surged 50% in 6 monthsGNG Electronics witnessed a Rs 175 crore block deal as promoter Vidhi Khandelwal sold shares to domestic mutual funds and foreign investors...
- Honasa Consumer, 6 other stocks hit 52-week highs, rally up to 35% in a monthDespite weakness in the broader market, seven BSE 500 stocks including Honasa Consumer, Aegis Logistics and Gland Pharma scaled fresh 52-we...
- Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...
- ADIA to sell 2.3% Lenskart stake in Rs 1,944 crore block dealAbu Dhabi Investment Authority is set to divest a 2.3% stake in Lenskart for approximately Rs 1,944 crore via a block deal. This follows So...
- Stocks in news: Emcure Pharma, Dixon Technologies, Ajanta Pharma, Godrej Properties, VedantaIndian markets experienced a volatile session, closing higher amidst mixed signals. Bulls are defending the 23,000 level in Nifty, but unce...
- PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stakePrivate equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per sha...
- Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MFA promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya B...
- SBI in $1 billion funding for Sun Pharma’s US dealState Bank of India is set to commit up to $1 billion to fund Sun Pharmaceutical Industries Ltd.'s $12 billion acquisition of Organon & Co....
Load More
